tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Beijing Chunlizhengda Reports Stable Interim Financial Results for 2025

Story Highlights
Beijing Chunlizhengda Reports Stable Interim Financial Results for 2025

Meet Your ETF AI Analyst

The latest update is out from Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H ( (HK:1858) ).

Beijing Chunlizhengda Medical Instruments Co., Ltd. announced its unaudited consolidated interim results for the first half of 2025, showing a stable financial position with total assets amounting to RMB 3.49 billion as of June 30, 2025. The company’s current assets slightly increased, driven by a rise in held-for-trading financial assets, while its non-current assets also saw a modest increase, indicating ongoing investments in fixed assets and construction projects.

The most recent analyst rating on (HK:1858) stock is a Hold with a HK$18.00 price target. To see the full list of analyst forecasts on Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H stock, see the HK:1858 Stock Forecast page.

More about Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H

Beijing Chunlizhengda Medical Instruments Co., Ltd. is a joint stock limited company incorporated in China, operating in the medical instruments industry. The company focuses on the production and distribution of medical devices, with a specific emphasis on the Chinese market.

Average Trading Volume: 1,934,100

Technical Sentiment Signal: Buy

Current Market Cap: HK$8.29B

For detailed information about 1858 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1